PAR-21-226 : Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed)
Release Date: 2021-04-30
Grant Status: open
Due Date: Multiple
2021-09-06
2022-01-05
2022-04-05
2022-09-05
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
Close Date: 2024-09-06
Description
Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms
PAR-21-225 : Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed)
Release Date: 2021-04-30
Grant Status: open
Due Date: Multiple
2021-09-05
2022-01-05
2022-04-05
2022-09-05
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
2024-09-05
Close Date: 2024-09-06
Description
Many NIH-funded research projects rely on vertebrate and invertebrate animal models to study the basics of biology and physiology, to investigate pathological conditions, to examine disease mechanisms
PAR-21-282 : Blueprint Medtech: Small Business Translator (U44 - Clinical Trial Optional)
Release Date: 2021-08-20
Grant Status: open
Due Date: Multiple
2021-10-20
2022-02-18
2022-06-20
2022-10-18
2023-02-21
2023-06-20
2023-10-18
2024-02-20
2024-06-20
Close Date: 2024-06-21
Description
Blueprint MedTech
The NIH Blueprint for Neuroscience Research is a collaborative framework through which 14 NIH Institutes, Centers and Offices jointly support neuroscience-related research, with t
PAR-21-233 : Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
Release Date: 2021-04-23
Grant Status: open
Due Date: Multiple
2021-08-10
2022-02-09
2022-08-09
2023-02-09
2023-08-09
2024-02-09
Close Date: 2024-04-06
Description
A. Overview
Recent advances in biology offer unprecedented opportunities to discover new treatments for nervous system disorders. Biotherapeutic development, however, has inherent complexities with
PAR-21-224 : NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
Release Date: 2021-05-05
Grant Status: open
Due Date: Multiple
2021-09-06
2022-01-05
2022-04-05
2022-09-05
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
Close Date: 2024-04-06
Description
Purpose:
To facilitate the cooperation and partnering of public and private funding organizations, universities, academic medical centers, research institutes, contract research organizations, biot
PAR-21-267 : NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required)
Release Date: 2021-07-16
Grant Status: open
Due Date: Multiple
2021-09-05
2022-01-05
2022-04-05
2022-09-05
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
Close Date: 2024-04-06
Description
Purpose
NINDS is committed to advancing diagnostics and treatments for people burdened by neurological diseases, and the NINDS Small Business Innovation Research (SBIR) and Small Business Technology
PAR-21-265 : NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
Release Date: 2021-07-16
Grant Status: open
Due Date: Multiple
2021-09-05
2022-01-05
2022-04-05
2022-09-05
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
Close Date: 2024-04-06
Description
Purpose
NINDS is committed to advancing diagnostics and treatments for people burdened by neurological diseases, and the NINDS Small Business Innovation Research (SBIR) and Small Business Technolog
PAR-21-266 : NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Release Date: 2021-07-16
Grant Status: open
Due Date: Multiple
2021-09-05
2022-01-05
2022-04-05
2022-09-05
2023-01-05
2023-04-05
2023-09-05
2024-01-05
2024-04-05
Close Date: 2024-04-06
Description
Purpose
NINDS is committed to advancing diagnostics and treatments for people burdened by neurological diseases, and the NINDS Small Business Innovation Research (SBIR) and Small Business Technolog
A. Purpose
The purpose of this Funding Opportunity Announcement (FOA) is to encourage investigators to pursue translational activities and small clinical studies to advance the development of thera
Purpose
This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigato